From Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring Attitude, & Other Highlights from Seattle Life Sciences 2029:

friend2029

friend2029—

Stephen Friend is the co-founder and CEO of Sage Bionetworks.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Sponsored · Whitepaper
COVID-19 Special Report: Sustaining Clinical Research During the Crisis
Leveraging technology & expertise to ensure a continual journey from trials to treatments
PRA Health Sciences

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!